Gyre Therapeutics Stock Forecast
Recent Gyre Therapeutics Stock Price | Gyre Therapeutics Stock Forecast Price | |
$0.00 | NA% |
$0.00 |
Recent Gyre Therapeutics Analyst Ratings Breakdown | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | ||||
Buy ratings: | ||||
Hold ratings: | ||||
Sell ratings: | ||||
Strong sell ratings: | ||||
Average rating: |
The presented Gyre Therapeutics stock forecast (traded under symbol CBIO), for forward-twelve-months price target as shown at the top of this page, gives you the average Gyre Therapeutics stock forecast for forward target price for symbol CBIO, across the analysts covering Gyre Therapeutics (CBIO), as reported in data provided by Zacks Investment Research via Quandl.com.
Investors should also take note that the median Gyre Therapeutics stock forecast price target (i.e. representing the middle ground number where half of analysts had a higher Gyre Therapeutics stock forecast and half had a lower Gyre Therapeutics stock forecast) was $ as of (which is a different mathematical metric versus taking the average or mean), while the
highest Gyre Therapeutics stock forecast in the analyst group was $, and the lowest Gyre Therapeutics stock forecast in the analyst group was
$, with a standard deviation of $. Get the latest Zacks research report on CBIO — FREE
Top Analyst Picks of the Dow
The Top 20 Largest U.S. Stocks By Market Cap
|
Free CBIO Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |